Kofi Sarfo-Kantanka, MD, Internal Medicine, Nashville, TN

KofiSarfo-KantankaMD

Internal Medicine Nashville, TN

Hospital Medicine/Hospitalist

Resident Physician

Dr. Sarfo-Kantanka is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sarfo-Kantanka's full profile

Already have an account?

Summary

  • Multifaceted, well trained, innovative and highly talented PGY-3 Internal Medicine Resident Physician with unwavering commitment to high quality and value-based patient care. Extensive background working with veterans, underprivileged and medically underserved populations. A visionary in advancing goals through clinical research and grow within the dynamic needs of any healthcare system.

Education & Training

  • Meharry Medical CollegeClass of 2016
  • University of OregonBS, Biology, Society of College Scholars, 2006 - 2011

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2020 - 2022

Publications & Presentations

PubMed

Journal Articles

  • Hypofractionated Radiation Therapy in the Treatment of Anaplastic Thyroid Cancer  
    M.J. Stavas, E. Shinohara, K. Sarfo-Kantanka and A. Cmelak, International Journal of Radiation Oncology, Biology, Physics, 1/2/2014

Abstracts/Posters

  • A Comparison of Helical Tomotherapy with Standard Radiotherapy Treatment Planning (AP/PA) in Patients with Wilms' Tumor and Ewing's Sarcoma
    Kofi Sarfo-Kantanka, Richard Crilly and Logan Moll, Proceedings of the Eleventh Annual AACR International Conference on Frontiers in Cancer Prevention Research / Cancer Prev Res, Anaheim, CA, 10/16/2012

Grant Support

  • Meharry-VICC-TSU Cancer PartnershipNational Cancer Institute (NCI)2015–2016

Research History

  • Visiting Research Medical Student at Vanderbilt University Medical CenterI was part of the team that performed a retrospective series investigating the effectiveness and tolerability of hypofractionated radiation therapy in treatment of Anaplastic Thyroid Cancer (ATC). We demonstrated the safety and feasibility of hypofractionated radiotherapy in the treatment of ATC.2012 - 2013
  • Visiting Scientist at Oregon Health and Science UniversityWe conducted a comparison study of two radiotherapy treatment planning and delivery approaches in patients with Wilm's tumor and Ewing's sarcoma. It was observed that the helical tomotherapy is better for treating volumes that minimize dose to normal tissues and supply uniform doses.2012 - 2012